Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral
Summary
This condition involves diabetes mellitus resulting from an underlying health issue, accompanied by proliferative diabetic retinopathy without macular edema in both eyes. Proliferative diabetic retinopathy is an advanced stage of retinal damage caused by prolonged high blood sugar, characterized by the growth of abnormal blood vessels on the retina. The absence of macular edema means the central part of the retina (macula) is not swollen, though the abnormal vessel growth still poses a risk of vision impairment if unmanaged. The bilateral specification indicates the condition affects both eyes.
Causes
The condition arises when an underlying disease impairs insulin production or function, leading to secondary diabetes. Examples of such underlying conditions include pancreatic disorders, hormonal imbalances, or genetic syndromes. Persistent hyperglycemia from this secondary diabetes damages retinal blood vessels, triggering proliferative changes. The lack of macular edema suggests the retinal damage has not yet caused fluid accumulation in the macula, and the bilateral specification indicates the condition is present in both eyes.
Risk Factors
- Having a medical condition known to cause secondary diabetes.
- Long-standing uncontrolled blood sugar levels.
- High blood pressure and elevated cholesterol.
- Smoking and obesity.
- Advanced age.
Symptoms
- Blurred or distorted vision in both eyes.
- Floaters or spots in the visual field.
- Difficulty seeing in low light.
- Sudden vision loss (if abnormal blood vessels bleed).
Diagnosis
Diagnosis involves a comprehensive eye exam, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal blood vessel growth and rule out macular edema. Blood tests to confirm diabetes and identify underlying causes may also be performed. Bilateral involvement is confirmed by evaluating both eyes.
Treatment Options
- Managing the underlying condition to control blood sugar levels.
- Laser photocoagulation or anti-VEGF injections to reduce abnormal blood vessel growth.
- Regular monitoring to detect progression or complications.
- Blood pressure and cholesterol management to reduce retinal damage risk.
Prognosis and Follow-Up
Prognosis depends on timely treatment and blood sugar control. With proper management, vision loss can be minimized, but proliferative changes require ongoing monitoring. Follow-up typically includes regular eye exams every 3–6 months to assess retinal status and adjust treatment as needed.
Complications
- Vision impairment or blindness if untreated.
- Retinal detachment from abnormal blood vessel growth.
- Glaucoma due to increased eye pressure.
- Increased risk of other diabetes-related complications (e.g., kidney disease).
Lifestyle & Prevention
- Maintain strict blood sugar control through diet, exercise, and medication.
- Quit smoking and limit alcohol intake.
- Monitor blood pressure and cholesterol regularly.
- Attend routine eye exams to detect early retinal changes.
When to Seek Professional Help
Seek immediate care for sudden vision changes, eye pain, or floaters, as these may indicate bleeding or retinal detachment. Regular follow-up with an ophthalmologist is essential for ongoing management.
Tips for Medical Coders
Document the underlying condition causing diabetes, the presence of proliferative diabetic retinopathy, and the absence of macular edema. Specify bilateral involvement to support the code. Ensure clinical notes confirm both eyes are affected and no macular edema is present.
E08.3593 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.